Utilizing glycerol
as a plasticizer, an accelerated physical stability
testing method of amorphous solid dispersions (ASDs) was developed.
The influence of glycerol concentration on the glass transition temperature
and α-relaxation time (a measure of molecular mobility) of amorphous
ketoconazole, celecoxib, and the solid dispersions of each prepared
with polyvinylpyrrolidone was investigated. By temperature scaling
(T
g/T), the effects of
glycerol concentration and temperature on the relaxation time were
simultaneously evaluated. Glycerol, in a concentration dependent manner,
accelerated crystallization in all of the systems without affecting
the fragility. In celecoxib-PVP ASDs, the drug crystallization was
well coupled to molecular mobility and was essentially unaltered at
glycerol concentrations up to 2% w/w. The acceleration in crystallization
brought about by glycerol expedited the determination of the coupling
between molecular mobility and crystallization. As a result, we were
able to predict the physical stability of the unplasticized ASD. This
approach is especially useful for ASDs with high polymer content where
drug crystallization is extremely slow at the relevant storage temperature.